MoonLake Immunotherapeutics
MLTX · Pharmaceutical Preparations
Latest available SEC filing: SCHEDULE 13G ·
Latest disclosures
-
Form SCHEDULE 13G/A
SEC filing · Filed
-
Form SCHEDULE 13G
SEC filing · Filed
-
Latest financial period: Q2 2026
Financial facts · Filed
-
Form 10-Q
SEC filing · Filed
-
Reich Kristian: Form 4
Insider disclosure · Filed · Report period 27 Jul 2026
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
Institutional holders by security
Choose a share class to see reported 13F positions and quarterly changes. Different securities have separate holder histories.
- MLTX · 61559X104 - COMMON STOCK
Company details and SEC sources
CIK 0001821586 · SEC filing index. Filing dates describe disclosures, not live market data.
- Listed symbols
- MLTX on Nasdaq
- SEC industry group
- Pharmaceutical Preparations (Office of Life Sciences)
- Business address
- Dorfstrasse 29, Zug, Switzerland, 6300
- Incorporated in
- Cayman Islands
- Fiscal year end
- 31 December
- Former names on EDGAR
- Helix Acquisition Corp (to 31 Mar 2022)
At a glance
Names, identifiers, and filing context for this profile.
2 identity fields